Online Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending
Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
GSK Removes Blenrep From U.S. Market, Due Poor Clinical Trial Performance for Multiple Myeloma DrugBlenrep failed to meet the goals of a confirmatory clinical trial required by the FDA to keep its accelerated approval license. November 23, 2022 Irvin Jackson Add Your CommentsThe blood cancer medication Blenrep will be removed from the market in the United States, following clinical trials that cast doubt on the effectiveness of the drug, according to an announcement this week by GlaxoSmithKline.Blenrep (belanatamab mafodin-blmf) was given fast-track approval by the FDA in August 2022, for the treatment of relapsed/refractory multiple myeloma. The drug was approved based on early preliminary clinical trials, and was dependent upon further clinical trials to keep that approval.On November 22, GlaxoSmithKline (GSK) issued a press release announcing it has begun the process of withdrawing Blenrep from the U.S. market, following disappointing Phase III clinical trial results, which did not show that Blenrep reached the efficacy requirements of the FDAโs Accelerated Approval program.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe clinical trial, known as DREAMM-3, was supposed to show Blenrep was better than existing treatments on the market, but failed to do so. But earlier this month, GSK indicated the confirmatory trial had failed to produce the results required by the agency.However, GSK says it still has hopes for the drug, and clinical trials will continue. The company also indicated current Blenrep patients in the U.S. will have the option to continue receiving the drug, and other patients may enroll for access to it.There are still two scheduled Phase III clinical trials expected to produce results in the first half of 2023, known ad DREAMM-7 and DREAMM-8. GSK will have to apply for a new biologics approval if those studies show Blenrep to be both safe and effective.Blenrep is still approved for use in 17 other countries, most of those in Europe. The drug has already generated about $105 million in sales to date, with two-thirds of that being sold in the U.S. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Blenrep, Cancer, Clinical Trials, GlaxoSmithKline, Multiple MyelomaMore Lawsuit Stories Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers November 13, 2026 Port Catheter Lawsuit Links SmartPort to Infections, Sepsis November 13, 2026 Online Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending November 13, 2026 1 Comments ANNE-MARIE December 4, 2023 I trying to find out if there is any lawsuits out on the Myeloma drug Blenrep. I had a reaction that effected my kidneys with high Albumin levels that set off a chain of events affecting my kidneys. This persisted after stopping the drug. I new of the eye issues that go along with Blenrep and yes I had those but it was the Albumin issues that cause me not to be able to be in a Car – T cell or Abecma treatment also clinical trials. This persistent for almost a year and took some time working with my Nephrologist. This was not a side effect that I was aware of. My Oncologist only found this side effect later and did not seem to be published. I would like to go after the manufacturer of Blen Rep . Any help would be appreciated, EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026) Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026) Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)
Online Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending November 13, 2026
Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)
Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026)
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)